Skip to main content

Table 2 Odds ratios for surgical treatmenta for people with non-metastatic non-small cell lung cancer in NSW 2001–2007b

From: Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit

  Odds ratioc (95 % CI) p-value
Aboriginal 0.70 (0.46–1.05) 0.084
Sex   0.042
 Male 1.00  
 Female 1.12 (1.00–1.24)  
Age at diagnosis (years)   <0.001
 18–49 1.00  
 50–59 0.89 (0.68–1.15)  
 60–69 0.90 (0.70–1.14)  
 70–79 0.58 (0.46–0.74)  
 80+ 0.20 (0.15–0.27)  
Spread of disease   <0.001
 Localised 1.00  
 Regional 0.81 (0.73–0.90)  
Year of diagnosis 1.04 (1.02–1.07) 0.001
Place of residence at diagnosis   <0.001
 Major cities 1.00  
 Inner regional 0.69 (0.60–0.80)  
 Rurald 0.66 (0.51–0.83)  
Comorbiditiese   
 Chronic pulmonary disease 1.04 (0.93–1.16) 0.526
 Diabetes 1.08 (0.93–1.25) 0.300
 Cardiovascular disease 0.71 (0.62–0.82) <0.001
 Renal disease 0.74 (0.56–0.97) 0.029
 Other comorbidities 0.60 (0.49–0.72) <0.001
Socioeconomic disadvantage quintile <0.001
 Least disadvantaged 1.00  
 Second least disadvantaged 0.86 (0.73–1.02)  
 Third least disadvantaged 0.73 (0.61–0.87)  
 Second most disadvantaged 0.85 (0.72–1.01)  
 Most disadvantaged 0.63 (0.51–0.76)  
  1. CI confidence interval
  2. aSurgical treatment includes pneumonectomy, lobectomy, lung resection or resection of endotracheal tumour
  3. bThere were 120 Aboriginal and 6757 non-Aboriginal people in this analysis
  4. cOdds ratio adjusted for all other variables in the table
  5. dRural includes outer regional, remote and very remote
  6. ePresence vs absence of each comorbidity